Colorectal cancer (CRC) is one of the leading causes of cancer death worldwide.1 Recently, the most important progress in treatment of CRC may be the treatments of targeting EGFR or targeting PD1/PDL1 based on the discoveries of these biomarkers.2–5. Here, EGFR is linked to colorectal carcinoma.